Clinipace Worldwide (Durham, NC) a commercial-stage global digital clinical research organization specializing in strategic product and clinical development, closed a $15M Series C financing. Participants include Morgan Stanley, Hatteras Venture Partners and Brook Private Equity Advisors.

The 3Q11 OnBioVC Trend Analysis Will Be Available Next Monday 31 October